CD8+ cells from asymptomatic human immunodeficiency virus-infected individuals suppress superinfection of their peripheral blood mononuclear cells

Journal of General Virology

Volumn 77, Issue 12, 1996, Pages 2953-2962

  Barker, Edward ^a   Bossart, Katharine N ^a   Locher, Christopher P ^a   Patterson, Bruce K ^b   Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SUPERINFECTION; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION; VIRUS RESISTANCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0030465616     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-12-2953     Document Type: Article

References (48)

1. + cell response against human immunodeficiency virus: implications for long-term survival. Proceedings of the National Academy of Sciences, USA 92, 11135-11139.
2. + T cells: evidence for a soluble inhibitor. Journal of Immunology 144, 2961-2966.
3. + T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. Journal of Virology 65, 2019-2023.
4. Castro, B. A., Weiss, C. D., Wiviott, L. D. & Levy, J. A. (1988). Optimal conditions for recovery of the human immunodeficiency virus from peripheral blood mononuclear cells. Journal of Clinical Microbiology 26, 2371-2376.
5. Castro, B. A., Barnett, S. W., Evans, L. A., Moreau, J., Odehouri, K. & Levy, J. A. (1990). Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2). Virology 178, 527-534.
6. + T cells. Science 270, 1811-1815.
7. Evans, L. A., McHugh, T. M., Stites, D. P. & Levy, J. A. (1987). Differential ability of human immunodeficiency virus isolates to productively infect human cells. Journal of Immunology 138, 3415-3418.
8. Gao, F., Yue, L., Robertson, D. L., Hill, S. C., Hui, H., Biggar, R. J., Neequaye, A. E., Whelan, T. M., Ho, D. D., Shaw, G. M., Sharp, P. M. & Hahn, B. H. (1994). Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. Journal of Virology 68, 7433-7447.
9. Harper, M. E., Marselle, L. M., Gallo, R. C. & Wong-Staal, F. (1986). Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proceedings of the National Academy of Sciences, USA 83, 772-776.
10. Hoffman, A. D., Banapour, B. & Levy, J. A. (1985). Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147, 326-335.
11. Hoxie, J. A., Alpers, J. D., Rackowski, J. L., Huebner, K., Haggarty, B. S., Cedarbaum, A. J. & Reed, J. C. (1986). Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV. Science 234, 1123-1127.
12. + T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. Journal of Virology 64, 3399-3406.
13. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
14. + T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clinical Immunology and Immunopathology 69, 106-116.
15. LeGuern, M. & Levy, J. A. (1992). HIV-1 can superinfect HIV-2-infected cells: pseudotype virions produced with expanded cellular host range. Proceedings of the National Academy of Sciences, USA 89, 363-367.
16. Leonard, G., Chaput, A., Courgnaud, V., Sangare, A., Denis, F. & Brechot, C. (1993). Characterization of dual HIV-1 and HIV-2 serological profiles by polymerase chain reaction. AIDS 7, 1185-1189.
17. Levy, J. A. (1993). HIV pathogenesis and long-term survival. AIDS 7, 1401-1410.
18. Levy, J. A. (1994). HIV and the Pathogenesis of AIDS. Washington, DC: American Society for Microbiology.
19. Levy, J. A. & Shimabukuro, J. (1985). Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions, and from clinically healthy individuals. Journal of Infectious Diseases 152, 734-738.
20. Levy, J. A., Tobler, L. H., McHugh, T. M., Casavant, C. H. & Stites, D. P. (1985). Long-term cultivation of T cells subsets from patients with acquired immune deficiency syndrome. Clinical Immunology and Immunopathology 35, 328-336.
21. + cells. Immunology Today 17, 217-224.
22. + cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Research and Human Retroviruses 8, 1039-1050.
23. + cell anti-HIV activity correlates with the clinical state of the infected individual. Journal of Clinical Investigation 87, 1462-1466.
24. + cells suppress HIV replication by inhibiting viral transcription. Proceedings of the National Academy of Sciences, USA 92, 2308-2312.
25. + T cell-mediated suppression of HIV replication: relevance of known chemokines and other cytokines. XI International Conference on AIDS 1, 226.
26. McNearney, T., Hornickova, Z., Markham, R., Birdwell, A., Arens, M., Saah, A. & Ratner, L. (1992). Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease. Proceedings of the National Academy of Sciences, USA 89, 10247-10251.
27. Meyerhans, A., Vartanian, J. P., Hultgren, C., Plikat, U., Karlsson, A., Wang, L., Erikkson, S. & Wain-Hobson, S. (1994). Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. Journal of Virology 68, 535-540.
28. Oravecz, T., Pall, M. & Norcross, M. A. (1996). β-Chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step. Journal of Immunology 157, 1329-1332.
29. Pan, L.-Z., Cheng-Mayer, C. & Levy, J. A. (1987). Patterns of antibody response in individuals infected with the human immunodeficiency virus. Journal of Infectious Diseases 155, 626-632.
30. + peripheral blood lymphocytes in healthy seropositive individuals. Journal of Virology 63, 4626-4631.
31. Putkonen, P., Welther, L., Zhang, Y. Z., Li, S. L., Nilsson, C., Albert, J., Biberfeld, P., Thorstensson, R. & Biberfeld, G. (1995). Long-term protection against SIV-induced disease in macaques vaccinated with a live attenuated HIV-2 vaccine. Nature Medicine 1, 914-918.
32. Robertson, D. L., Sharp, P. M., McCutchan, F. E. & Hahn, B. H. (1995). Recombination in HIV-1. Nature 374, 124-126.
33. Salmon, P., Olivier, R., Riviere, Y., Brisson, E., Gluckman, J.-C., Kieny, M.-P., Montagnier, L. & Klatzmann, D. (1988). Loss of CD4 membrane expression and CD4 mRNA during acute human immunodeficiency virus replication. Journal of Experimental Medicine 168, 1953-1969.
34. Shirazi, Y. & Pitha, P. M. (1992). Alpha Interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. Journal of Virology 66, 1321-1328.
35. Shirazi, Y. & Pitha, P. M. (1993). Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 193, 303-312.
36. Taddeo, B., Federico, M., Titti, F., Rossi, G. B. & Verani, P. (1993). Homologous superinfection of both producer and nonproducer HIV-infected cells is blocked at a late retrotranscription step. Virology 194, 441-452.
37. + T cells are infectible by human immunodeficiency virus but do not release virus after activation. Journal of Virology 69, 5659-5665.
38. Tateno, M. & Levy, J. A. (1988). MT-4 plaque formation can distinguish cytopathic subtypes of the human immunodeficiency virus (HIV). Virology 167, 299-301.
39. Towbin, H., Staehelin, T. & Gordon, J. (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, USA 76, 4350-4355.
40. Travers, K., Mboup, S., Marlink, R., Gueye-Ndiaye, A., Siby, T., Thior, I., Traore, I., Dieng-Sarr, A., Sankale, J.-L., Mullins, C., Ndoye, I., Hsieh, C.-C., Essex, M. & Kanki, P. (1995). Natural protection against HIV-1 infection provided by HIV-2. Science 268, 1612-1615.
41. Tremblay, M., Numazaki, K., Li, X. G., Gornitsky, M., Hiscott, J. & Weinberg, M. A. (1990). Resistance to infection by HIV-1 of peripheral blood mononuclear cells from HIV-1-infected patients is probably mediated by neutralizing antibodies. Journal of Immunology 145, 2896-2901.
42. Tsubota, H., Lord, C. I., Watkins, D. I., Morimoto, C. & Letvin, N. L. (1989). A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. Journal of Experimental Medicine 169, 1421-1434.
43. Volsky, D. J., Simm, M., Shahabuddin, M., Li, G., Chao, W. & Potash, M. J. (1996). Interference to human immunodeficiency virus type 1 infection in the absence of downmodulation of the principal virus receptor, CD4. Journal of Virology 70, 3823-3833.
44. Walker, B. D. & Plata, F. (1990). Cytotoxic T lymphocytes against HIV. AIDS 4, 177-184.
45. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-1566.
46. + cells involves a noncytotoxic mechanism. Journal of Virology 65, 5921-5927.
47. + T cells from HIV-1-infected individuals inhibit acute infection by human and primate immunodeficiency viruses. Cellular Immunology 137, 420-428.
48. Werner, A. & Levy, J. A. (1993). Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. Journal of Virology 67, 2566-2574.